Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.

pharmacogenomics --- return of results --- genetic counseling --- qualitative --- pharmacogenetics --- implementation --- pharmacogenetics service --- screening --- pre-emptive --- personalized medicine --- precision medicine --- community pharmacy --- pharmacogenomic testing --- genetic privacy --- pharmaco-economics --- polymorphisms --- pharmacogenes --- pharmacogenomic --- machine learning --- adaptation --- human evolution --- US Food and Drug Administration --- clinical actionability --- clinical translation --- chronic kidney disease --- CYP3A5 --- polymorphism --- progression --- pharmacogenomics (PGx) --- pediatrics --- best practice alerts (BPAs) --- electronic health records (EHR) --- genomic indicators --- clinical decision support (CDS) --- phenotype --- genotype --- polypharmacy --- chronic disease --- medication management --- electronic medical record --- artificial intelligence --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Genomic and Precision Medicine: Oncology, Third Edition focuses on the applications of genome discovery as research points to personalized cancer therapies. Each chapter is organized to cover the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field. -- Publisher

Cancer --- Personalized medicine. --- Neoplasms --- Genomics --- Precision Medicine. --- Precision Medicine --- P Health --- P-Health --- Personalized Medicine --- Theranostics --- Individualized Medicine --- Predictive Medicine --- Medicine, Individualized --- Medicine, Personalized --- Medicine, Precision --- Medicine, Predictive --- Theranostic --- Pharmacogenomic Variants --- Pharmacogenetics --- Patient-Specific Modeling --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Individualized medicine --- Medical care --- Cancer genetics --- Cancer genes --- Genetic aspects. --- methods --- Precision medicine. --- Personalized medicine --- Genetic Techniques --- Genetics, Medical --- Proteomics --- genetics --- methods. --- Neoplasms. --- genetics.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This colligated Special Issue of Pharmaceutics on Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy offers to the reader a series of articles that describe the concept of Precision Medicine, discuss its implementation process and limitations, demonstrate its value by illustrating some clinical cases, and open the door to new and more sophisticated techniques and applications.

fibromyalgia (FM) --- myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) --- microRNA --- miRNome --- pharmacogenomics --- pharmacoepigenomics --- SM2miR --- Pharmaco-miR --- repoDB --- ME/CFS Common Data Elements (CDEs) --- dihydropyrimidine dehydrogenase --- DPYD --- 5-fluorouracil --- fluoropyrimidine --- therapeutic drug monitoring --- orthotopic liver transplant --- busulfan --- glutathione S-transferase --- genetic polymorphism --- limited sampling strategy --- pharmacokinetics --- clinical pharmacogenetics --- pharmacogenetic testing --- adverse drug reactions --- genotype --- phenotype --- pharmacogene --- barriers to pharmacogenetics implementation --- Sub-Saharan Africa --- chronic low back pain (cLBP) --- genetics --- personalized treatment --- polymorphism --- CYP450 --- tacrolimus --- CYP3A5 --- liver transplant --- pharmacogenomic --- minority --- data collection --- drug --- biomarker --- pharmacogenetics --- pharmacogenetic test --- personalized medicine --- gene expression --- infliximab --- adalimumab --- ulcerative colitis --- Crohn disease --- inflammatory bowel disease --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Breast Neoplasms. --- Precision Medicine. --- P Health --- P-Health --- Personalized Medicine --- Theranostics --- Individualized Medicine --- Predictive Medicine --- Medicine, Individualized --- Medicine, Personalized --- Medicine, Precision --- Medicine, Predictive --- Theranostic --- Pharmacogenomic Variants --- Pharmacogenetics --- Patient-Specific Modeling --- Breast Carcinoma --- Cancer of the Breast --- Human Mammary Carcinoma --- Malignant Neoplasm of Breast --- Malignant Tumor of Breast --- Mammary Cancer --- Mammary Carcinoma, Human --- Mammary Neoplasm, Human --- Mammary Neoplasms, Human --- Neoplasms, Breast --- Tumors, Breast --- Breast Cancer --- Breast Tumors --- Cancer of Breast --- Breast Carcinomas --- Breast Malignant Neoplasm --- Breast Malignant Neoplasms --- Breast Malignant Tumor --- Breast Malignant Tumors --- Breast Neoplasm --- Breast Tumor --- Cancer, Breast --- Cancer, Mammary --- Cancers, Mammary --- Carcinoma, Breast --- Carcinoma, Human Mammary --- Carcinomas, Breast --- Carcinomas, Human Mammary --- Human Mammary Carcinomas --- Human Mammary Neoplasm --- Human Mammary Neoplasms --- Mammary Cancers --- Mammary Carcinomas, Human --- Neoplasm, Breast --- Neoplasm, Human Mammary --- Neoplasms, Human Mammary --- Tumor, Breast --- Breast Cancer Lymphedema --- Breast --- Cancer --- Treatment. --- Cancer.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients’ experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.

Precision Medicine. --- Biomarkers, Tumor. --- Biochemical Tumor Markers --- Biological Tumor Marker --- Biological Tumor Markers --- Biomarkers, Cancer --- Marker, Biochemical Tumor --- Marker, Biologic Tumor --- Marker, Biological Tumor --- Marker, Neoplasm Metabolite --- Marker, Tumor Metabolite --- Markers, Biochemical Tumor --- Markers, Biological Tumor --- Markers, Neoplasm Metabolite --- Markers, Tumor Metabolite --- Metabolite Markers, Tumor --- Neoplasm Metabolite Markers --- Tumor Markers, Biologic --- Tumor Metabolite Marker --- Biochemical Tumor Marker --- Cancer Biomarker --- Carcinogen Markers --- Markers, Tumor --- Metabolite Markers, Neoplasm --- Tumor Biomarker --- Tumor Marker --- Tumor Markers, Biochemical --- Tumor Markers, Biological --- Biologic Tumor Marker --- Biologic Tumor Markers --- Biomarker, Cancer --- Biomarker, Tumor --- Cancer Biomarkers --- Marker, Tumor --- Markers, Biologic Tumor --- Markers, Carcinogen --- Metabolite Marker, Neoplasm --- Metabolite Marker, Tumor --- Neoplasm Metabolite Marker --- Tumor Biomarkers --- Tumor Marker, Biochemical --- Tumor Marker, Biologic --- Tumor Marker, Biological --- Tumor Markers --- Tumor Metabolite Markers --- Neoplasm Proteins --- P Health --- P-Health --- Personalized Medicine --- Theranostics --- Individualized Medicine --- Predictive Medicine --- Medicine, Individualized --- Medicine, Personalized --- Medicine, Precision --- Medicine, Predictive --- Theranostic --- Pharmacogenomic Variants --- Pharmacogenetics --- Patient-Specific Modeling --- cancer biomarkers --- Sociology of medicine --- Science and Technology Studies --- Oncology --- Philosophy of medicine --- precision oncology --- personalised cancer treatments --- health technology assessment --- Open access